Paysign price target raised to $8 from $7 at DA Davidson
DA Davidson analyst Peter Heckmann raised the firm’s price target on Paysign (PAYS) to $8 from $7 and keeps a Buy rating on the shares. Last week, Paysign announced the company had been awarded 132 established plasma donation centers through an expansion of a relationship with a major plasma collection company, and the firm believes this will increase the company’s total plasma locations to 613 centers, a 27% increase over the 484 locations served at the end of Q1, the analyst tells investors in